Treatment of melanoma in-transit metastases confined to the limb

Cancer Surveys

Volumn 26, Issue , 1996, Pages 335-349

  Eggermont, A M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

CANCER RISK; DRUG EFFICACY; HUMAN; LIMB PERFUSION; MELANOMA; PRIORITY JOURNAL; REVIEW; SKIN METASTASIS; TREATMENT OUTCOME;

CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; EXTREMITIES; HUMANS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0029541070     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Asher AL, Mule JJ, Reichert CM, Shiloni E, Rosenberg SA (1987) Studies of the antitumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. Journal of Immunology 138 963-974
2. Benckhuijsen C, Kroon BBR, Van Geel AN and Wieberdink J (1988) Regional perfusion treatment with melphalan for melanoma in a limb: evaluation of drug kinetics. European Journal of Surgical Oncology 14 157-163
3. Bland KI, Kimura AK, Brenner DE et al (1989) A Phase II study of the efficacy of diamminedichloroplatinum (cisplatin) for the control of locally recurrent and intransit malignant melanoma of the extremities using tourniquet outflow-occlusion techniques. Annals of Surgery 209 73-80